Targeted PARACEST nanoparticle contrast agent for the detection of fibrin
✍ Scribed by Patrick M. Winter; Kejia Cai; Junjie Chen; Christopher R. Adair; Garry E. Kiefer; Phillip S. Athey; Patrick J. Gaffney; Carolyn E. Buff; J. David Robertson; Shelton D. Caruthers; Samuel A. Wickline; Gregory M. Lanza
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 394 KB
- Volume
- 56
- Category
- Article
- ISSN
- 0740-3194
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
A lipid‐encapsulated perfluorocarbon nanoparticle molecular imaging contrast agent that utilizes a paramagnetic chemical exchange saturation transfer (PARACEST) chelate is presented. PARACEST agents are ideally suited for molecular imaging applications because one can switch the contrast on and off at will simply by adjusting the pulse sequence parameters. This obviates the need for pre‐ and postinjection images to define contrast agent binding. Spectroscopy (4.7T) of PARACEST nanoparticles revealed a bound water peak at 52 ppm, in agreement with results from the water‐soluble chelate. Imaging of control nanoparticles showed no appreciable contrast, while PARACEST nanoparticles produced >10% signal enhancement. PARACEST nanoparticles were targeted to clots via antifibrin antibodies and produced a contrast‐to‐noise ratio (CNR) of 10 at the clot surface. Magn Reson Med, 2006. © 2006 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract A targeted Gd^3+^‐based contrast agent has been developed that detects tumor cell death by binding to the phosphatidylserine (PS) exposed on the plasma membrane of dying cells. Although this agent has been used to detect tumor cell death in vivo, the differences in signal intensity betw